Could blood from a cancer's own vein reveal more tumor DNA?

NCT ID NCT05497531

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study compares two ways of collecting blood to detect circulating tumor DNA (ctDNA) in people with liver or pancreatic cancers. Researchers will take blood from a standard arm vein and also from the vein that drains directly from the tumor during a biopsy. The goal is to see if the tumor-draining vein sample contains more or different tumor DNA. Only 15 participants are being enrolled, so this is an early-stage exploration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more sensitive way to detect tumor DNA, potentially improving cancer monitoring and treatment decisions.
What could go wrong
This is a very small pilot study with only 15 participants, so results may not apply broadly. The procedure is also more invasive than a standard blood draw.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMPULLARY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Chao Family Comprehensive Cancer Center, University of California, Irvine

    RECRUITING

    Orange, California, 92868, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.